Equities
Health CarePharmaceuticals and Biotechnology
  • Price (EUR)22.00
  • Today's Change-0.20 / -0.90%
  • Shares traded29.00
  • 1 Year change-8.33%
  • Beta--
Data delayed at least 15 minutes, as of Nov 12 2024 07:14 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of GBP
(except for per share items)
Fiscal data as of Jun 30 2024202420232022
ASSETS
Cash And Short Term Investments433639
Total Receivables, Net128128125
Total Inventory898584
Prepaid expenses9.607.708.50
Other current assets, total1.901.501.20
Total current assets271259258
Property, plant & equipment, net479483505
Goodwill, net110108111
Intangibles, net656672
Long term investments626251
Note receivable - long term128.208.60
Other long term assets1.204.902.20
Total assets1,0291,0081,018
LIABILITIES
Accounts payable343536
Accrued expenses7.307.709.00
Notes payable/short-term debt000
Current portion long-term debt/capital leases191417
Other current liabilities, total909189
Total current liabilities151147151
Total long term debt272218207
Total debt291232224
Deferred income tax445160
Minority interest(4.3)(7.7)(6.4)
Other liabilities, total182428
Total liabilities481433439
SHAREHOLDERS EQUITY
Common stock6.606.606.60
Additional paid-in capital179179179
Retained earnings (accumulated deficit)351361341
Treasury stock - common(0.1)(0.1)(0.1)
Unrealized gain (loss)------
Other equity, total112952
Total equity548575579
Total liabilities & shareholders' equity1,0291,0081,018
Total common shares outstanding666666
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.